Loading provider…
Loading provider…
Hematology & Oncology Physician in Columbus, OH
NPI: 1558453977Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get MD, PHD David's Phone Numberphone_androidMobile
Get MD, PHD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
OH State Medical License
OH State Medical License
2012 - 2027
TN State Medical License
1996 - 2013
TX State Medical License
1992 - 1997
MD State Medical License
1988 - 1992

American Board of Internal Medicine
Internal Medicine
The Johns Hopkins University School of Medicine
hopkinsmedicine.org
Medical School
Until 1985
National Institutes of Health Clinical Center
Fellowship • Hematology and Medical Oncology
1988 - 1991
Johns Hopkins University
Residency • Internal Medicine
1985 - 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 43 | 123 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
Authors: Huang, Yuhui, Carbone, David P
Journal: Biochim Biophys Acta
Publication Date: 2015-01-15
Authors: Dennis Slamon, John Minna, Valerie Rusch
Journal: Chest
Authors: Reck, M, Ciuleanu, T-E, Cobo, M, Schenker, M, Zurawski, B, Menezes, J, Richardet, E, Bennouna, J, Felip, E, Juan-Vidal, O, Alexandru, A, Sakai, H, Lingua, A, Reyes, F, Souquet, P-J, De Marchi, P, Martin, C, Pérol, M, Scherpereel, A, Lu, S, Paz-Ares, L, Carbone, D P, Memaj, A, Marimuthu, S, Zhang, X, Tran, P, John, T
Journal: ESMO Open
Publication Date: 2021-12-02
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Rovalpituzumab tesirine
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: carboplatin, OTHER: laboratory biomarker analysis, DRUG: paclitaxel, BIOLOGICAL: bevacizumab, GENETIC: proteomic profiling, OTHER: matrix-assisted laser desorption/ionization time of flight mass spectrometry